Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurobiol Aging. 2012 May;33(5):1001.e1-6. doi: 10.1016/j.neurobiolaging.2011.03.011. Epub 2011 Apr 30.

Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.

Author information

  • 1Department of Neuroscience, Rosalind Franklin University/The Chicago Medical School, North Chicago, IL, USA.

Abstract

Intracellular Ca(2+) dysregulation is an underlying component of Alzheimer's disease (AD) pathophysiology, and recent evidence implicates the ryanodine receptor (RyR) in the disease pathway. Three genes code for different RyR isoforms and each gene transcript gives rise to several alternatively spliced messenger RNAs (mRNAs). These variants confer distinct functionality to the RyR channel, such as altering Ca(2+) release properties or subcellular localization. Changes in RyR isoform expression and alternative splicing have not been examined for potential roles in AD pathogenesis. Here, we compare mRNA levels of the RyR2 and RyR3 isoforms as well as specific alternatively spliced variants across vulnerable brain regions from postmortem samples of individuals with no cognitive impairment (NCI), mild cognitive impairment (MCI), and AD. We find an increase in RyR2 transcripts in MCI brains compared with no cognitive impairment. In addition, there is a reduction in a RyR2 splice variant, associated with an antiapoptotic function, in MCI and AD brains. These alterations in RyR expression at early disease stages may reflect the onset of pathologic mechanisms leading to later neurodegeneration.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
21531043
[PubMed - indexed for MEDLINE]
PMCID:
PMC3160507
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk